We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Mass Spectrometry Strategies in Metabolomics

In this mini review, researchers from The Samuel Roberts Noble Foundation review various mass spectrometry technologies utilized in metabolomics and suggest future needs.
News

Emerging Tactical Strategies for Fighting the War on Cancer Based on the Genetic Landscape

This article discusses several high impact areas of global sequencing projects including developing drugs that specifically target cancer cells.
News

Fifteen US plant scientists win huge grants - $75M

Fifteen of US's most innovative plant scientists to join a new initiative that boosts much needed funding for fundamental plant science research.
News

What Makes A Plant A Plant?

Scientists have identified a list of proteins encoded in the genomes of plants and green algae, but not in the genomes of organisms that don't generate energy through photosynthesis
News

IDBS Leads Stratified Medicine Consortium

The UK’s national innovation agency, the Technology Strategy Board, has selected an IDBS-led consortium to create an informatics platform to support stratified and translational medicine research and cross-organizational collaboration.
News

Protein Attributes Contribute To Halo-Stability, Bioinformatics Approach

In this article researchers have examined protein features that contribute to the halo-toleration of halophilic organisms.
News

Building Protein-Protein Interaction Networks with Proteomic and Informatics Tools

This review focuses on the recent development of protein interaction networks derived from quantitative proteomics datasets.
News

USPTO Grants Two New Patents to Metabolon

Metabolon currently holds 17 US Patents related to its biochemical profiling methods, data analysis solutions and biomarkers for disease and toxicity.
News

AVI BioPharma and NMRC Successfully Complete Simultaneous Rapid-Response Exercises Against Bacterial and Viral Threats in 18 Days

PMO-based platform chemistries used by AVI to design and manufacture novel RNA-based drug candidates against both undisclosed bacterial and viral targets.
News

Adaptimmune Announces Opening of Phase I/II Clinical Trial for Metastatic Melanoma

The Phase I/II, two cohort, open label clinical trial in metastatic melanoma opens at Washington University, St. Louis, Missouri.
Advertisement